Unisarsh Pharmaceuticals Private Limited
About Unisarsh Pharmaceuticals Private Limited
Data last updated:
Unisarsh Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 09 July 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51397BR2013PTC020706. Its GSTIN is 10AABCU6057B1ZX (Bihar).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Rizwana Khatoon (Whole-Time Director) and Tabassum Fatma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Imam Colony Near Imam Colony Masjid Phulwari Sharif, Patna, Bihar, India – 801505.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.23 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹1.05 Lakh (net margin 0.9%) and EBITDA of ₹2.57 Lakh (EBITDA margin 2.1%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Unisarsh Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressImam Colony Near Imam Colony Masjid Phulwari Sharif, Patna, Bihar, India – 801505
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Unisarsh Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Unisarsh Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Unisarsh Pharmaceuticals Private Limited, buy the company report.
Financials of Unisarsh Pharmaceuticals Private Limited
FY 2025 filings availableUnisarsh Pharmaceuticals Private Limited reported revenue of ₹1.23 Cr (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 5% in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.57 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unisarsh Pharmaceuticals Private Limited, buy the company report.
Board of directors of Unisarsh Pharmaceuticals Private Limited
Unisarsh Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tabassum Fatma Also directs: Unisarsh Lifecare Private Limited | Director | 09 Jul 2013 | 13 Years 3 Months | Current |
| Rizwana Khatoon | Whole-Time Director | 29 Feb 2016 | 10 Years 8 Months | Current |
| Syed Mohamad Shahab | Director | 09 Jul 2013 | 13 Years 3 Months | Current |
Peer comparison
Unisarsh Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dermont Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2025) | 14.0% | Jaipur, Rajasthan, India | |||
| Elixolife Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2025) | -22.0% | Pilkhuwa, Uttar Pradesh, India | |||
| Sinista Pharmaceuticals Private Limited | ₹1.23 Cr (FY 2025) | 31.0% | New Delhi, Delhi, India | |||
| Unisarsh Pharmaceuticals Private Limitedthis company | ₹1.23 Cr (FY 2025) | ₹1.05 Lakh | 0.9% | 5.0% | Patna, Bihar, India |
To see the full peer comparison of Unisarsh Pharmaceuticals Private Limited, buy the company report.
Auditor
Unisarsh Pharmaceuticals Private Limited is audited by SUNAND MUKHERJEE & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUNAND MUKHERJEE & CO. | FY 2017 | 013440C |
Shareholding
The shareholding of Unisarsh Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Unisarsh Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Unisarsh Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unisarsh Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unisarsh Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AABCU6057B1ZX | Bihar | Active | 13 Apr 2022 |
To see the full GST registrations and return filing status of Unisarsh Pharmaceuticals Private Limited, buy the company report.
Recent activity
Unisarsh Pharmaceuticals Private Limited has 6 board changes on record since 2013: 3 appointments and 3 cessations. The latest: Ghazala Jabeen Ahmad ceased to be Whole-Time Director on 11 Apr 2019.
Frequently asked questions
Unisarsh Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in other wholesale, within the trading industry. It was incorporated on 09 July 2013 (13+ years old) and is registered under CIN U51397BR2013PTC020706.
Unisarsh Pharmaceuticals has 3 current directors:
- Rizwana Khatoon - Whole-Time Director
- Tabassum Fatma - Director
- Syed Mohamad Shahab - Director
The latest financial statements of Unisarsh Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Unisarsh Pharmaceuticals is 10AABCU6057B1ZX, registered in Bihar.
The CIN (Corporate Identification Number) of Unisarsh Pharmaceuticals is U51397BR2013PTC020706. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unisarsh Pharmaceuticals was incorporated on 09 July 2013, making it 13+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Unisarsh Pharmaceuticals by revenue are Dermont Pharmaceuticals Private Limited, Elixolife Pharmaceuticals Private Limited, Sinista Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ghazala Jabeen Ahmad ceased to be Whole-Time Director on 11 Apr 2019. Mohammad Sarfaraz Ahmad ceased to be Director on 11 Apr 2019. Rizwana Khatoon was appointed as Whole-Time Director on 29 Feb 2016. Unisarsh Pharmaceuticals has 6 board changes on record in total.
The registered office of Unisarsh Pharmaceuticals is at Imam Colony Near Imam Colony Masjid Phulwari Sharif, Patna, Bihar, India – 801505.
Unisarsh Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Unisarsh Pharmaceuticals is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
